Overview


Stent Delivery Systems Market Introduction
Stents are placed in the body to open or to give support to the organ and delivery through this stent makes a very easy way to administer a drug or correct the abnormality in the organ. Nowadays, stent delivery systems are usually designed for through-the-scope (TTS) deployment, whereas some SEMS (self-expandable metallic stents) designs are delivered over a guide wire using fluoroscopy, also referred to as over-the-wire (OTW). With OTW delivery systems, the endoscopist can also reintroduce the endoscope alongside the stent delivery system for an endoscopic view during SEMS deployment. Most systems also allow for recapture and repositioning of the SEMS until a certain “point of no return” has been reached.
Stent delivery system offers precise and intuitive deployment of the stent during a medical intervention. It reduces medical errors and improves patient compliance during the stenting process. Increasing demand of delivery systems in healthcare settings led to the robust growth of the market. Along with this, growing research activities has shown delivery systems are more reliable and easy to use than traditional methods. Further, government bodies are more focused on offering sustained healthcare services to minimize the cost burden. It led to the rapid development of special delivery systems to minimize the complications and to improve the patient outcome. It indirectly led to the potential growth of the market. Further, growing technologies have fuelled the development process of delivery systems during the forecast period.
North America market is expected to witness high market share in the global market due to established healthcare systems and reimbursement policies. It is followed by the European region and it accounts a significant share in the global market due to high adoption among the end user segment. Asia-Pacific region is expected to witness a high market growth rate during the forecast period. Latin America and Rest of the world market are expected to witness significant growth during the forecast period due to the increasing presence of international players.
Stent Delivery Systems market players include
Boston Scientific Corporation, Abbott, B. Braun Melsungen AG, Medtronic, Stryker, Biotronik, C.R. Bard and others
By Material Type
Cobalt-Chromium Delivery System
Stent-on-a-wire delivery system
Others
By End User
Hospital
Ambulatory Surgical Centres
Catheterization Laboratories
By Region
North America
Latin America
Europe
Asia Pacific
Middle East and Africa

Tier 1 players- established companies in the market with a major market share

Tier 2 players

Emerging players which are growing rapidly

New Entrants
FutureWise Key Takeaways

Growth prospects

SWOT analysis

Key trends

Key data-points affecting market growth

To provide with an exhaustive analysis on the global Stent Delivery Systems Market by Material Type, by End-User, and by Region

To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)

To evaluate and forecast micro-markets and the overall market

To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East

To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions

Profiling of companies to evaluate their market shares, strategies, financials and core competencies

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Stent Delivery Systems Market Variables, Trends
    • Scope
        1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Type Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances
  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Stent Delivery Systems Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Stent Delivery Systems Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Stent Delivery Systems Market, By Material Type Historical Analysis and Forecast 2022-2028 (USD Million)
    •   1. Cobalt-Chromium Delivery System
        2. Stent-on-a-wire delivery system
        3. Others
  • 8.   Stent Delivery Systems Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million)
    •   1. Hospital
        2. Ambulatory Surgical Centres
        3. Catheterization Laboratories
  • 9.   North America Stent Delivery Systems Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
           2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2022-2028
  • 10.   Latin America Stent Delivery Systems Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2022-2028
  • 11.   Europe Stent Delivery Systems Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         2.1. Germany
          2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2022-2028
  • 12.   Asia Pacific Stent Delivery Systems Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
  • 13.   Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2022-2028
  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Boston Scientific Corporation
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Abbott
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
         3. B. Braun Melsungen AG
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Medtronic
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Stryker
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Biotronik
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
          7. C.R. Bard
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 17.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients